Abstract:Gut microbiota is explicitly associated with the development of depressive disorder. However, the molecular pathogenesis associated with gut microbiota with MDD remains unclear. Shugan granule (SGKL), a Chinese patent medicine, is a potential anti‐depression drug via gut microbiota, but the molecular therapeutic mechanism of SGKL remains unknown for the depression process. Our previous study determined SGKL might contribute to alleviating depression symptoms through the PI3K/Akt/mTOR pathway. There is a lack of the investigation to demonstrate whether SGKL can target PI3K/Akt/mTOR pathway based on altered gut microbiota, leading to the improvement of depression progression. We showed a novel mechanism of gut microbiota in causing depression; gut microbiota cause changes in phosphorylation of the PI3K/Akt/mTOR pathway, which mediates microglial activation and subsequent inflammation, eventually causing the development of depression. Importantly, SGKL treatment targets the PI3K/Akt/mTOR pathway in improving depression‐like behaviour, microglia activation, and inflammation. Moreover, we concluded that Parasutterella, Aeromonas, Ruminococcaceae_UCG_008, Globiocatella, Shuttleworthia, and Clostridium_sensu_stricto_1 were the biomarkers of depression, and Candidatus Arthromitus might be the therapeutic target of SGKL during improving depressive‐like behaviours. These findings suggests that SGKL may be the reliable and rational drug for the treatment in depression. Aim The investigation aims to evaluate the potential effect of Shugan Granule (SGKL) on the gut, brain, and behaviors in rats exposed to chronic restraint stress (CRS). Methods The fecal microbiota and metabolite changes were studied in rats exposed to CRS and treated with SGKL (0.1 mg/kg/day). Depressive behaviors of these rats were determined through an open‐field experiment, forced swimming test, sucrose preference, and weighing. Moreover, LPS‐stimulated microglia and CRS‐stimulated rats were treated with SGKL to investigate the regulation between SGKL and the PI3K/Akt/pathway, which is inhibited by LY294002, a PI3K inhibitor. Results (i) SGKL improved the altered behaviors in CRS‐stimulated rats; (ii) SGKL ameliorated the CRS‐induced neuronal degeneration and tangled nerve fiber and also contributed to the recovery of intestinal barrier injury in these rats; (iii) SGKL inhibited the hippocampus elevations of TNF‐α, IL‐1β, and IL‐6 in response to CRS modeling; (iv) based on the principal coordinates analysis (PCoA), SGKL altered α‐diversity indices and shifted β‐diversity in CRS‐stimulated rats; (v) at the genus level, SGKL decreased the CRS‐enhanced abundance of Bacteroides; (vi) Butyricimonas and Candidatus Arthromitus were enriched in SGKL‐treated rats; (vii) altered gut microbiota and metabolites were correlated with behaviors, inflammation, and PI3K/Akt/mTOR pathway; (viii) SGKL increased the LPS‐decreased phosphorylation of the PI3K/Akt/mTOR pathway in microglia and inhibited the LPS‐induced microglial activation; (ix) PI3K/Akt/mTOR pathway inactivation reversed the SGKL effects in CRS rats. Conclusion SGKL targets the PI3K/Akt/mTOR pathway by altering gut microbiota and metabolites, which ameliorates altered behavior and inflammation in the hippocampus.

Dietary sulforaphane glucosinolate mitigates depression-like behaviors in mice with hepatic ischemia/reperfusion injury: A role of the gut-liver-brain axis

Prophylactic Effects of Sulforaphane on Depression-Like Behavior and Dendritic Changes in Mice after Inflammation

Antidepressant effects of sulforaphane (SFN) and its derivatives SLL-III-9 and SLL-III-120 and their potential underlying mechanisms based on the microbiota–gut–brain axis

Protective Effect of Sulforaphane Against Depressive Behavior in Mice Through Glucocorticoid Receptor Antagonism

Saccharina japonica Ethanol Extract Ameliorates Depression/Anxiety-Like Behavior by Inhibiting Inflammation, Oxidative Stress, and Apoptosis in Dextran Sodium Sulfate Induced Ulcerative Colitis Mice

Trans-Resveratrol Ameliorates Stress-Induced Irritable Bowel Syndrome-Like Behaviors by Regulation of Brain-Gut Axis.

Gastrodin ameliorates depressive-like behaviors via modulating gut microbiota in CUMS-induced mice

The Protective Effect of Broccoli Seed Extract against Lipopolysaccharide-Induced Acute Liver Injury via Gut Microbiota Modulation and Sulforaphane Production in Mice

Sulforaphane Improves Liver Metabolism and Gut Microbiota in Circadian Rhythm Disorder Mice Models Fed With High-Fat Diets.

Sesamol ameliorates dextran sulfate sodium-induced depression-like and anxiety-like behaviors in colitis mice: the potential involvement of the gut-brain axis

Depression-like phenotypes in mice following common bile duct ligation: Insights into the gut-liver-brain axis via the vagus nerve

Ginkgo biloba extract protects against depression-like behavior in mice through regulating gut microbial bile acid metabolism

Involvement of the Gut-Brain Axis in Vascular Depression Via Tryptophan Metabolism: A Benefit of Short Chain Fatty Acids.

Alpha-glycosyl isoquercitrin alleviates subchronic social defeat stress-induced depression symptoms by modulating the microbiota-gut-brain axis in mice

Rice Germ Ameliorated Chronic Unpredictable Mild Stress-Induced Depressive-like Behavior by Reducing Neuroinflammation

Shugan granule contributes to the improvement of depression‐like behaviors in chronic restraint stress‐stimulated rats by altering gut microbiota

Study on Lactiplantibacillus plantarum R6-3 from Sayram Ketteki to prevents chronic unpredictable mild stress-induced depression in mice through microbe-gut-brain axis

Cuscutae semen alleviates CUS-induced depression-like behaviors in mice via the gut microbiota-neuroinflammation axis

Role of Keap1-Nrf2 Signaling in Depression and Dietary Intake of Glucoraphanin Confers Stress Resilience in Mice

Crocetin ameliorates chronic restraint stress-induced depression-like behaviors in mice by regulating MEK/ERK pathways and gut microbiota

Prophylactic effects of supplementation of a combination of Lactobacillus lactis WHH2078 and saffron on depressive-like behaviors in mice exposed to chronic stress